MediWound (MDWD) Revenue Growth (5y) (2019 - 2025)
MediWound (MDWD) Revenue Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | MediWound | 165.19 Mn | 160.39 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.49% |
| Sep 30, 2025 | 11.99% |
| Jun 30, 2025 | 11.56% |
| Mar 31, 2025 | -2.28% |
| Dec 31, 2024 | 1.42% |
| Sep 30, 2024 | -3.26% |
| Jun 30, 2024 | 11.72% |
| Mar 31, 2024 | 64.35% |
| Dec 31, 2023 | 40.01% |
| Sep 30, 2023 | 42.49% |
| Jun 30, 2023 | 4.07% |
| Mar 31, 2023 | 48.84% |
| Dec 31, 2022 | 85.43% |
| Sep 30, 2022 | 51.01% |
| Jun 30, 2022 | 19.43% |
| Mar 31, 2022 | 52.18% |
| Dec 31, 2021 | 66.41% |
| Sep 30, 2021 | 38.54% |
| Jun 30, 2021 | 47.99% |
| Mar 31, 2021 | 58.21% |